Literature DB >> 23575355

Agreement among cardiovascular disease risk calculators.

G Michael Allan1, Faeze Nouri, Christina Korownyk, Michael R Kolber, Ben Vandermeer, James McCormack.   

Abstract

BACKGROUND: Use of cardiovascular disease risk calculators is often recommended by guidelines, but research on consistency in risk assessment among calculators is limited. METHOD AND
RESULTS: A search of PubMed and Google was performed. Five clinicians selected 25 calculators by independent review. Hypothetical patients were created with the use of 7 risk factors (age, sex, smoking, blood pressure, high-density lipoprotein, total cholesterol, and diabetes mellitus) dichotomized to high and low, generating 2(7) patients (128 total). These patients were assessed by each calculator by 2 clinicians. Risk estimates (and assigned risk categories) were compared among calculators. Selected calculators were from 8 countries, used 5- or 10-year predictions, and estimated either cardiovascular disease or coronary heart disease. With the use of 3 risk categories (low, medium, and high), the 25 calculators categorized each patient into a mean of 2.2 different categories, and 41% of unique patients were assigned across all 3 risk categories. Risk category agreement between pairs of calculators was 67%. This did not improve when analysis was limited to just the 10-year cardiovascular disease calculators. In nondiabetics, the highest calculated risk estimate from a calculator averaged 4.9 times higher (range, 1.9-13.3) than the lowest calculated risk estimate for the same patient. This did not change meaningfully for diabetics or when the analysis was limited to 10-year cardiovascular disease calculators.
CONCLUSIONS: The decision as to which calculator to use for risk estimation has an important impact on both risk categorization and absolute risk estimates. This has broad implications for guidelines recommending therapies based on specific calculators.

Entities:  

Keywords:  cardiovascular risk calculator; risk assessment

Mesh:

Substances:

Year:  2013        PMID: 23575355     DOI: 10.1161/CIRCULATIONAHA.112.000412

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

Review 1.  Arterial structure and function in vascular ageing: are you as old as your arteries?

Authors:  Dick H J Thijssen; Sophie E Carter; Daniel J Green
Journal:  J Physiol       Date:  2015-07-27       Impact factor: 5.182

Review 2.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

3.  Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.

Authors:  G Michael Allan; Adrienne J Lindblad; Ann Comeau; John Coppola; Brianne Hudson; Marco Mannarino; Cindy McMinis; Raj Padwal; Christine Schelstraete; Kelly Zarnke; Scott Garrison; Candra Cotton; Christina Korownyk; James McCormack; Sharon Nickel; Michael R Kolber
Journal:  Can Fam Physician       Date:  2015-10       Impact factor: 3.275

Review 4.  Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium.

Authors:  Waqas T Qureshi; Jamal S Rana; Joseph Yeboah; Usama Bin Nasir; Mouaz H Al-Mallah
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

Review 5.  Evolution of lipid management guidelines: evidence might set you free.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

6.  Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes.

Authors:  Rachel G Miller; Trevor J Orchard; Tina Costacou
Journal:  Diabetes Res Clin Pract       Date:  2020-04-08       Impact factor: 5.602

Review 7.  Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.

Authors:  Francesco Paneni; Sarah Costantino; Francesco Cosentino
Journal:  Cardiovasc Diagn Ther       Date:  2014-08

Review 8.  Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Authors:  Narendra S Choudhary; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 9.  Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Authors:  Mohammed E Al-Sofiani; Robert Derenbecker; Michael Quartuccio; Rita R Kalyani
Journal:  Curr Diab Rep       Date:  2019-09-23       Impact factor: 4.810

Review 10.  Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model Database.

Authors:  Benjamin S Wessler; Lana Lai Yh; Whitney Kramer; Michael Cangelosi; Gowri Raman; Jennifer S Lutz; David M Kent
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.